Harry M. Jansen Kraemer, Jr. has served on Option Care Health's Board since 2019.  He is an independent chair of the Board, chair of the Nominating & Corporate Governance Committee, and member of the Audit Committee of the Board.

Mr. Kraemer has served as executive partner of Madison Dearborn Partners, a private equity firm, since 2005.  Before this, he served as Chairman, President, and Chief Executive Officer of Baxter International, Inc., a global, publicly-traded manufacturer of diagnostic and other health-care related products.  He has also held the role of Clinical Professor of Management and Strategy at the Kellogg School of Management at Northwestern University since 2005.  He currently serves on one other public company board: Leidos Holdings, Inc. (NYSE: LDOS). 

Mr. Kraemer brings to the Board strategic leadership and extensive financial expertise through his more than 30 years of proven executive-level experience in the healthcare industry as well as his significant experience on other boards of directors of private and public companies.  Through his experience at biotechnology and pharmaceutical companies, he also brings significant expertise in the health sector and with technology and innovation.

Elizabeth Q. Betten has served on Option Care Health's Board since 2019.  She is an independent director, chair of the Finance & Investment Committee, and member of the Quality & Compliance Committee of the Board.

Ms. Betten has served as Managing Director and Co-Head of the Health Care Team at Madison Dearborn Partners, LLC, a private equity investment firm, since January 2023 and has held various other positions there from since 2008, including as Managing Director from 2017 to 2022.  Before this, she was an investment banking analyst for the Health Care group at J.P. Morgan (2002-2004).   She serves on the board of directors of a number of private companies. 

Ms. Betten brings to the Board a wealth of experience with growing companies in the healthcare sector, including with financial transactions, capital allocation, and business development, as well as significant experience in risk management oversight and governance through her many years of service on other boards of directors.

Elizabeth D. Bierbower joined Option Care Health's board of directors in April 2022. She is an independent director and member of the Audit Committee and Quality & Compliance Committee of the Board.

From 2022-2023, Ms. Bierbower served as Chairman, Chief Executive Officer and a director of Friday Health Plans, a health insurance company.  Before this, she served in various leadership roles at Humana, a health insurance company, including as Segment President (2018-2020), President of Employer Group Segment (2012-2018), Chief Operating Officer of Specialty Benefits (2008-2012), and Vice President of Product Innovation (2001-2008). She serves on the board of directors of a number of private companies.

Ms. Bierbower brings to the Board strategic leadership, operational experience and financial expertise through her more than 30 years of proven executive-level experience in the health care industry as well as her service on other boards of directors.

Barbara W. Bodem joined Option Care Health's board of directors in January 2024.  She is an independent director and member of the Audit Committee and the Nominating & Corporate Governance Committee of the Board.

Ms. Bodem recently served as interim Chief Financial Officer for Dentsply Sirona Inc., the world's largest manufacturer of professional dental products and technologies. This follows her time as Senior Vice President and Chief Financial Officer for Hill-Rom (2018-2021), a medical technology provider that was acquired by Baxter International, Inc., and as Senior Vice President of finance for Mallinckrodt Pharmaceuticals (2015-2018).  She also held various leadership roles at Hospira (2013-2015), Eli Lilly and Company (1997-2013), and Irwin Management Company (1989-1997).

Ms. Bodem is an accomplished business leader and experienced board director with expertise in healthcare.  She currently serves on two other public company boards: Enovis Corporation (NYSE: ENOV) and BioMarin Pharmaceutical Inc. (NASDAQ: BMRN).

Eric K. Brandt joined Option Care Health's board of directors in May 2024. He is an independent director and member of the Compensation Committee and the Finance & Investment Committee of the Board.

Mr. Brandt is the former Chief Financial Officer at Broadcom, a Fortune 500 technology company (2007-2016). Prior to this, he served as President and Chief Executive Officer of Avanir Pharmaceuticals, Inc., a pharmaceutical manufacturing company (2005-2007) and as Chief Financial Officer of Allergan INC, a publicly-traded pharmaceutical company (1999-2005). He currently serves on three other public company boards: Gen Digital Inc. (NASDAQ: GEN); The Macerich Company (NYSE: MAC); and Lam Research Corporation (NASDAQ: LRCX). Until recently, he also served on the board of DENTSPLY Sirona Inc. (NASDAQ: XRAY) (2004-2024).

Mr. Brandt brings extensive public company governance experience, a track record of leading finance and information technology organizations, and corporate strategy and dealmaking expertise through his many years of service in the technology and health care sectors.

Natasha Deckmann, M.D. joined Option Care Health's board of directors in April 2022. She is an independent director, chair of the Quality & Compliance Committee, and member of the Audit Committee and Finance & Investment Committee of the Board.

Since March 2024, Dr. Deckmann has been serving as Chief Transformation Officer of Tivity Health, a national provider of health improvement, fitness and social engagement solutions. Prior to this, Dr. Deckmann served as Chief Operating Officer and Chief Clinical Officer of SecureSenior Connections, a digital platform focused on preventing and reducing loneliness and social isolation in seniors (2020-2023), and has also served in various leadership roles as Chief Executive Officer of CarePoint Health System, a three-hospital and medical group system in New Jersey (2018-2020) and as Chief Operating Officer, Consumer Solutions Group, of Optum, a UnitedHealth Group company (2013-2018).

Dr. Deckmann brings to the Board strategic leadership, operational experience and financial expertise through her more than 30 years of proven executive-level experience in the health care industry as well as her service on other boards of directors.

David W. Golding has served on Option Care Health's Board since 2015.  He is an independent director and member of the Compensation Committee of the Board.

Mr. Golding recently served as Director and Advisor for several private healthcare-oriented companies.  Prior to this, he served as Company Advisor to Twistle, provider of automated patient communication software (2017-2022) and as Executive Vice President of specialty pharmacy for CVS Health (1987-2011). 

Mr. Golding brings to the Board over 35 years of experience in the healthcare industry, particularly in home infusion and specialty pharmacy, hospital and retail sectors.  As a clinical pharmacist, Mr. Golding also brings unique perspectives on patient care.

R. Carter Pate has served on Option Care Health's Board since 2015.  He is an independent director, chair of the Audit Committee, and member of the Finance & Investment Committee of the Board.

Most recently, Mr. Pate served as Chief Executive Officer of Modivicare, a global holding company whose subsidiaries provide technology-enabled healthcare services (2017-2020).  Prior to this, he served as Chief Executive Officer of MV Transportation, Inc., a passenger transportation contracting firm (2011-2014) and as Global and U.S. Managing Partner, Health Care and Government Services Practice, of PricewaterhouseCoopers (1996-2012).  He currently serves on the board of directors of Purple Innovations, Inc. and previously served as chair of the board of directors of Red Lion Hotels (NASDAQ: RLH) from 2019 to 2020, and as a member of the board of directors of Advanced Emissions Solutions, Inc. (NASDAQ: ADES), a leader in environmental solutions for power generation, industrial and municipal water purification markets, from 2016 to 2021.

Mr. Pate brings to the Board strategic leadership, financial expertise, and significant experiences in public company corporate governance, public policy, and risk management oversight from his tenure at global companies and his service on other boards of directors.

John C. Rademacher is the president and chief executive officer of Option Care Health and has served on the Board since 2019. 

Prior to becoming President and Chief Executive Officer of Option Care Health in 2018, Mr. Rademacher served as Chief Operating Officer of the Company from 2015-2018.  This follows various leadership roles at Cardinal Health, Inc., a publicly-traded multinational health care services company, including as President, Ambulatory Care (2012-2014) and President, Nuclear & Pharmacy Services (2007-2012).  Prior to this, he served as Senior Vice President of Cigna, a publicly-traded health services company (2001-2007). 

Mr. Rademacher brings to the Board over 25 years of executive leadership experience in the healthcare industry, including the management of nationwide operations, sales, service and support related to the provision of home and alternate site infusion services.

Timothy P. Sullivan has served on Option Care Health's Board since 2019.  He is an independent director and member of the Compensation Committee of the Board.

Mr. Sullivan has held various leadership positions at Madison Dearborn Partners, LLC, a private equity firm, including as current Co-Chief Executive Officer (since 2022) and as Co-Founder, Managing Director, and Co-Head of Health Care Team (1992-2022).  He currently serves on the board of directors of a number of private healthcare companies as well as on the board of trustees of a number of non-profit organizations.

Mr. Sullivan brings to the Board deep financial expertise and a global business perspective.

Norman L. Wright joined Option Care Health's board of directors in January 2024. He is an independent director chair of the Compensation Committee and a member of the Nominating & Corporate Governance Committee of the Board.

Mr. Wright retired from UnitedHealth Group Incorporated in 2023 where he oversaw the company's health equity strategy as Executive Vice President, Health Equity Strategy.  Prior to this, Mr. Wright was the Chief Marketing and Customer Experience Officer for Optum, expanding on his prior role as Optum's Chief Customer Officer.  He also held other leadership roles at Citigroup Inc. (2007-2013), Accenture plc. (2004-2007), the Home Shopping Network (1999-2004), Fidelity Investments (1996-1999), GE Capital (1994-1996) and Chase Manhattan Bank (1990-1992). 

Mr. Wright currently serves on the board of directors of First Solar, Inc. (NASDAQ: FSLR), a global provider of photovoltaic solar energy systems. He previously served as Chairman of the United Health Foundation Board, UnitedHealth Group's Charitable Giving Committee and the UnitedHealth Group Equity Board and has also served on multiple nonprofit boards.

Mr. Wright brings to the Board strategic leadership, operational expertise, and extensive experience in human capital management, sustainability, and public company governance through his many years of service in the healthcare and financial sectors.